The pathogenesis and prognostic factors of scleritis

Recruiting

• Conditions: 10003816; Scleritis; inflammation of the sclera; 10021877

• Registration Number: NL-OMON55201
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 245

Inclusion Criteria

Patients with scleritis with a minimum age of 18 years.

Exclusion Criteria

Patients who are younger than 18 years old, who are mentally not competent, or
patients with insufficient knowledge of the Dutch language.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the difference in prevalence of specific<br /><br>auto-antibodies between patients with scleritis and controls. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Other study parameters are the differences between presence of MMPs, specific<br /><br>biomarkers and HLA associations between patients and controls. </p><br>